Sponsors

Co-organizer

IBM is working with pharmaceutical, life sciences and broader healthcare clients around the world to help create a profound transformation towards smarter business models and processes within the regulatory environment. Life Sciences companies must transform their business models and underlying R&D processes to integrate biomarker knowledge, embrace a new collaborative model of innovation, and to develop safe and effective patient / consumer centric offerings. From data analysis to clinical trial management to medical imaging and diagnostics, IBM can provide end-to-end solutions and services to help you integrate disparate data sources, automate and streamline research and business processes, share information and collaborate on findings, and facilitate regulatory compliance.

For more information, please visit ibm.com/industries/healthcare

Gold sponsor

RadPharm is a leading imaging core lab, managing the complete imaging segment of clinical trials for the global pharmaceutical, biotechnology and medical device industries. With greater than 15 years experience supporting over 350 clinical trials, across 60 countries and 5,000 unique sites, RadPharm employs board-certified, sub-specialty trained radiologists, nuclear physicians and medical oncologists, uniquely positioning us to focus on the Medicine Behind the ImageTM. Our experienced medical staff interprets data from all major modalities, including, but not limited to, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), X-ray, Single Photon Emission Computed Tomography (SPECT), Ultrasound, Positron Emission Tomography (PET) and PET/CT.

We provide centralized, independent, unbiased interpretation of medical images for clinical trials, integrated with a proven planning, tracking and implementation process specifically designed to exceed your expectations and timelines. RadPharm speeds delivery of your product to market by supporting your trial program with medical expertise, regulatory know-how and advanced, validated technologies.

www.radpharm.com

Silver sponsor

Cytel Inc. is a leading provider of clinical trial design services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. Cytel’s East® software system is used at hundreds of biopharmaceutical research sites, throughout academia, and by regulators to design, simulate and monitor adaptive and other complex clinical studies. Cytel provides trial sponsors with innovative tools, training, and consultation to increase the return on investment in clinical development.

www.cytel.com
.

Bronze sponsors

Covance is one of the world’s largest and most comprehensive drug development services companies, with more than 9,600 employees in over 20 countries. Covance has the people, processes, client service, and global resource capabilities to respond to biotechnology and pharmaceutical clients’ toughest drug development challenges.

With the most comprehensive portfolio of preclinical, clinical development and commercialization services, Covance provides industry-leading services, the world’s largest central laboratory network, and a global team of clinical trial and commercialization experts.

www.covance.com




Definiens is enabling personalized medicine through image analysis. At all powers of magnification, across all imaging modalities, and in all dimensions, Definiens extracts intelligence from images throughout the entire biomedical continuum, leading the way towards improving diagnosis and treatment of our most challenging diseases.

www.definiens.com

Nexus Oncology is a specialist CRO offering Oncology drug development services to the biopharmaceutical sector. Founded over 10 years ago, we maintain a commitment and focus to the conduct of oncology studies across Europe, the US and beyond. Nexus has an enviable reputation for high quality people and data, long standing relationships with Oncologists the world over and real client focus.

For further information please contact Lisa Bull, VP of Business Development.

www.nexusoncology.com

BioFortis was formed in 2002 by transfer of the Labmatrix™ technology from The Johns Hopkins Medical Institutes. The company gained recognition with prestigious early adopters such as NCI & NHGRI, and has since become a leading provider of information management solutions for the translational life science research community. The award-winning company supports researchers in a variety of application areas, including clinical and genetic research programs, biomarker studies, and biobanking in academic, government, and pharmaceutical sectors.
www.biofortis.com

Lunch Briefing sponsor

PharmaNet Development Group, a global, drug development services company, provides expertise to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet companies offer clinical development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. With more than 2,500 professionals in 42 offices around the world, PharmaNet is a recognized leader in outsourced clinical development.

www.pharmanet.com

©Copyright Phacilitate Limited 2009

» Click here to suggest a speaker or to contribute to the agendas

» Click here to review the Oncology Leaders' Forum Agenda

» Click here to review the R&D Leaders' Forum Agenda